X4 Pharmaceuticals Inc Cash Flow Quality Index
Latest as of March 2025:
-43.86x
X4 Pharmaceuticals Inc cash flow quality index. X4 Pharmaceuticals Inc (XFOR) has a Cash Flow Quality Index of -43.86x as of March 2025. Operating cash flow of $-12.37 Million is below net income of $282.00K, suggesting accrual-heavy earnings not yet converted to cash. See X4 Pharmaceuticals Inc (XFOR) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
-43.86x
Operating CF / Net Income
Operating Cash Flow
$-12.37 Million
USD
Net Income
$282.00K
USD
Data as of
Mar 2025
Most recent filing
X4 Pharmaceuticals Inc Cash Flow Quality Index by Year (None–None)
X4 Pharmaceuticals Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for X4 Pharmaceuticals Inc. For the full cash flow conversion analysis, see XFOR cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.